Eva Segelov

Monash University

Eva Segelov, MBBS, PhD, FRACP, is Professor of Medicine at Monash University and Director of Oncology at Monash Health, Melbourne, Australia. She is a practicing medical oncologist with more than 20 years’ experience, specializing in gastrointestinal cancer and neuroendocrine tumors, with an international reputation in clinical trials and translational research. Professor Segelov is a board member of the Australasian Gastrointestinal Trials Group; Gastrointestinal Chair of the Clinical Oncology Society of Australia; European Society of Medical Oncology faculty member for the CUP, Endocrine Tumours, and Others group; co-founder of the Commonwealth Neuroendocrine Tumour Society (CommNETS); Associate Editor of Journal of Global Oncology and a cancer editor for the Journal of Visualized Experiments. She heads a translational research laboratory specializing in interrogating clinical trial biospecimens. Professor Segelov has published more than 150 articles, expert reviews and book chapters and is a frequent invited speaker at national and international conferences. She is a member of the Australasian L\'Oréal-UNESCO for Women in Science jury.

Eva Segelov

1books edited

2chapters authored

Latest work with IntechOpen by Eva Segelov

An understanding of the molecular pathogenesis of colorectal cancer by researchers and clinicians is essential to facilitate progress in improving patient outcomes in this common cancer that still carries a poor prognosis if not identified early. This book covers the major areas of importance in the field, incorporating new knowledge that has arisen due to the advancement of molecular techniques and the ability to correlate molecular changes with clinical behaviour of tumours. Each chapter is a summary written by experts, concisely summarising current data as well as highlighting potential areas for advancement. Appreciating the differences between tumours on a molecular level is the key to developing and delivering precision medicine, and nowhere is this more critically required than in the field of colorectal cancer.

Go to the book